Quantum Biopharma Ltd (QNTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Operating Expenses | 9,803 | 6,022 | 13,155 | 4,829 | 6,685 |
| Operating Income | -9,803 | -6,022 | -13,155 | -4,829 | -6,685 |
| Interest Expense | 19 | 33 | 61 | 69 | 73 |
| Other Income | 416 | 2,091 | 814 | 972 | -1,402 |
| Pre-tax Income | -9,406 | -3,964 | -12,403 | -3,926 | -8,160 |
| Net Income Continuous | -9,406 | -3,964 | -12,403 | -3,926 | -8,160 |
| Net Income Discontinuous | -534 | -414 | -1,165 | -567 | -1,202 |
| Net Income | $-9,940 | $-4,378 | $-13,567 | $-4,493 | $-9,362 |
| EPS Basic Total Ops | -24.03 | 4.55 | -69.48 | -31.82 | -74.68 |
| EPS Basic Continuous Ops | -22.71 | 3.30 | -63.53 | -28.16 | -65.01 |
| EPS Basic Discontinuous Ops | -1.29 | 1.56 | -5.97 | -4.07 | -9.58 |
| EPS Diluted Total Ops | -24.03 | 4.55 | -69.48 | -31.82 | -74.68 |
| EPS Diluted Continuous Ops | -22.71 | 3.30 | -63.53 | -28.16 | -65.01 |
| EPS Diluted Discontinuous Ops | -1.29 | 1.56 | -5.97 | -4.07 | -9.58 |
| EBITDA(a) | $-8,852 | $-5,054 | $-12,189 | $-3,835 | $-5,713 |